REGIS CORP 10-Q

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities Share Issuance Program In February 2021, the Company filed a $150.0 million shelf registration statement and $50.0 million prospectus supplement with the SEC under which it may offer and sell, from time to time, up to $50.0 million worth of its common stock in "at-the-market" offerings. During the three months ended September 30, 2023, the Company did not issue shares under the prospectus supplement. On September 30, 2023, $11.6 million remains under the prospectus supplement, which equates to 16.5 million shares based on the share price as of September 30, 2023. Share Repurchase Program In May 2000, the Board approved a stock repurchase program with no stated expiration date. Since that time and through September 30, 2023, the Board has authorized $650.0 million to be expended for the repurchase of the Company's stock under this program. All repurchased shares become authorized but unissued shares of the Company. The Company last purchased shares in fiscal year 2020. As of September 30, 2023, a total accumulated 30.0 million shares have been repurchased for $595.4 million. At September 30, 2023, $54.6 million remains outstanding under the approved stock repurchase program. The Company does not expect to repurchase shares in fiscal year 2024.